← Back to all signals
RESEARCH PAPER ANALYSIS

Current Epidemiology and Infection Characteristics of Non-Aspergillus Mold Infections: A Multicenter Study in Australia and New Zealand.

AI interpretation is pending for this paper.

Open original publication →
PMID41562321
JournalClinical infectious diseases : an official publication of the Infectious Diseases Society of America
Publication Date2026-07-23
Ingested2026-08-02 12:07 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

BACKGROUND: Understanding the epidemiology of invasive non-Aspergillus mold infections is essential to inform effective therapy. This study aimed to determine the epidemiology and infection characteristics of non-Aspergillus mold infections in Australasia. METHODS: A 21-center, retrospective study of proven/probable non-Aspergillus mold infections from 2016 to 2023 was conducted in Australia and New Zealand. Data collected included demographic, clinical, microbiological, treatment, and outcome information through 180 days of follow-up. RESULTS: Of 421 cases, 346 (82.2%) were proven infections and 315 (74.8%) were localized. Lung (n = 150, 35.6%) was the most common site of infection. Twenty cases (4.8%) were due to >1 non-Aspergillus mold pathogen, resulting in 443 isolates in total. Dematiaceous molds, inclusive of Lomentospora prolificans (n = 96 of 443, 21.7%), Scedosporium spp. (n = 87 of 443, 19.6%), and other dematiaceous molds of various genera (n = 48 of 443, 10.8%), were the most common (n = 231 of 443, 52.1%), followed by Mucorales (n = 141 of 443, 31.8%). Common underlying conditions were hematological malignancy (n = 146, 34.7%) and diabetes mellitus (n = 122, 29.0%), while 68 cases (16.2%) had no comorbidities. One-third (n = 138, 32.8%) of patients received antifungal prophylaxis 30 days before non-Aspergillus mold diagnosis, and L. prolificans was the most common cause of breakthrough infections (P < .001). All-cause 90-day mortality was 31.4% (n = 132 of 421), with higher mortality observed in L. prolificans (n = 51 of 89, 57.3%) and Mucorales (n = 56 of 129, 43.4%) infections. CONCLUSIONS: Lomentospora prolificans, Scedosporium spp., and Mucorales are the most frequent non-Aspergillus mold pathogens in Australasia, with other emerging species and mixed infections encountered. Mortality from L. prolificans and Mucorales infections remains high.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Effects of early menarche on adolescent health: a single-centre retrospective study. Pediatric endocrinology, diabetes, and metabolism 68.4 2 Changes in the diagnosis and management of polycystic ovary syndrome in adolescents based on recommendations of scientific societies over the last decade. Pediatric endocrinology, diabetes, and metabolism 74.8 3 Development of a Behavioral Intervention, Increasing HPV Vaccine Uptake-Delivered in Dental Settings (HPV Vaccine Uptake-DDS). Behavioral medicine (Washington, D.C.) 61.4 4 A non-inferiority randomized controlled trial comparing nebulized fentanyl and intravenous morphine for acute pain management in the emergency department. BMC emergency medicine 77.6 5 Prevalence and behavioral factors associated with penile and rectal HPV infection among men who have sex with men in Kenya. BMC infectious diseases 71.0 6 Knowledge of cervical cancer and uptake of HPV vaccine among in-school adolescent girls in Kwara State, Nigeria. Infectious agents and cancer 75.7 7 Association of coping pathways with anxiety symptoms in children with hematological cancers: a cross-sectional study using regression and fuzzy-set qualitative comparative analysis. BMC psychology 70.4 8 Clinician vs. self-assessment of mFG hirsutism scores in PCOS: can patient self-assessment serve as a reliable screening and triage tool? BMC women's health 61.5 9 Impact of Obesity on Chemotherapy Pharmacokinetics, Toxicity, and Survival Outcomes in Pediatric Acute Lymphoblastic Leukemia. Cureus 75.0 10 Head & Neck and Shoulder Desmoid-Type Fibromatosis: Presentation and Natural History of These Ultra-Rare Locations. Cancer medicine 70.7 11 Leveraging Digital Histopathology to Build Capacity and Collaboration Toward the Diagnosis of Pediatric Solid Tumors in Mexico. JCO global oncology 59.9 12 [Newborn with neurofibromatosis type 1 and meningoencephalocele]. Ugeskrift for laeger 47.5 13 Central nervous system, cranial, and cerebrovascular conditions beyond the Kimonis criteria in patients with Gorlin syndrome: a retrospective cohort study. Frontiers in neurology 67.0 14 Resistance mechanisms and translational bottlenecks in CAR-T cell therapy for pediatric acute lymphoblastic leukemia: a perspective. Frontiers in immunology 84.27 15 Gut microbiota dysbiosis in pediatric acute lymphoblastic leukemia: clinical consequences, mechanistic insights, and microbiota-targeted interventions. Frontiers in pediatrics 82.6 16 Ewing sarcoma and paediatric cancer burden: we need more robust registries. Lancet regional health. Americas 47.5 17 Health and economic benefits of air quality improvements in France through diverse net-zero transition scenarios by 2050. Environment international 57.5 18 [Assessment of myocardial injury following anthracycline chemotherapy in children with leukemia by echocardiography]. Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 69.64 19 Thyroid Differentiation Score as a Molecular Bridge Between Genotype, Tumor Biology, and Radioiodine Theranostics in Thyroid Cancer. Endocrine-related cancer 64.7 20 [Development and validation of a prediction model for postoperative recurrence risk of ovarian endometriotic cysts based on preoperative imaging and clinical biomarkers]. Zhonghua yi xue za zhi 71.75 21 Lactation Management in Patients With Cancer: An Evidence-Based Framework for Surgical Practice. The American surgeon 71.0 22 Evidence-Based Recommendations for School Integration Programs Following Cancer: A Systematic Review. Journal of pediatric hematology/oncology nursing 70.0 23 Discharge Planning in Children With Cancer: Components, Strategies, and Outcomes-A Scoping Review (2021-2025). Journal of pediatric hematology/oncology nursing 58.0 24 Intervention to Support Families of Survivors of Pediatric Brain Tumor: A Scoping Review. Journal of pediatric hematology/oncology nursing 72.7 25 The role of allogeneic hematopoietic stem cell transplantation in adults with mature T-cell lymphomas. The Cochrane database of systematic reviews 88.6 26 Relative frequency of non-Wilms renal tumours in children: an institutional experience from a national tertiary referral centre in Malaysia. Pediatric surgery international 63.4 27 Childhood Cancer Risk After Assisted Reproductive Technology. JAMA 50.0 28 Long-Term Outcomes and Biomarker Correlates of a Multi-Institutional Phase II Study of Hypofractionated Proton Beam Therapy for Unresectable Primary Liver Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 83.39 29 The Burden of Early-Onset Gastric Cancer From 1990 to 2021: A Systematic Analysis for the Global Burden of Disease Study 2021. Journal of clinical gastroenterology 58.0 30 Decomposing the decline in life expectancy at birth by cause of death during the COVID-19 pandemic in Canada. Health reports 38.5 31 Integrating Surgery and Immunotherapy in the Treatment of Childhood Orbital Melanoma: A Case Report and the Literature Review. Ophthalmic plastic and reconstructive surgery 62.56 32 Co-occurrence of retinoblastoma and oculocutaneous albinism in a Mexican patient: a case report. Ophthalmic genetics 51.9
PATIENT-FRIENDLY SUMMARY

Current Epidemiology and Infection Characteristics of Non-Aspergillus Mold Infections: A Multicenter Study in Australia and New Zealand.

For education only—not personal medical advice.

Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic